Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) — Capital Reinvestment Ratio

Latest as of September 2024: 0.05x

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has a Capital Reinvestment Ratio of 0.05x as of September 2024, meaning it reinvests 0% of its operating cash flow ($753.12K) in capital expenditures ($41.04K). Check HKPD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$753.12K
USD

Capital Expenditures

$41.04K
USD

Data as of

Sep 2024
Most recent filing

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Capital Reinvestment Ratio (2023–2025)

This chart tracks Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see HKPD cash generation efficiency.

Annual Capital Reinvestment Ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)

Year-by-year Capital Reinvestment Ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025. See Hong Kong Pharma Digital Technology Hold free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.27x $569.21K $154.99K ▲ +299.5%
2023 0.07x $1.73 Million $117.70K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow